Trulieve Cannabis (TCNNF)

Trulieve Cannabis (TCNNF) Stock Price & Analysis


TCNNF Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$3.83 - $16.11
Previous Close$3.87
Average Volume (3M)403.17K
Market Cap
Enterprise Value$1.55B
Total Cash (Recent Filing)$188.13M
Total Debt (Recent Filing)$1.02B
Price to Earnings (P/E)-2.6
Aug 10, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.48
Shares Outstanding185,987,512
10 Day Avg. Volume316,750
30 Day Avg. Volume403,173
Standard Deviation0.19
Financial Highlights & Ratios
Price to Book (P/B)9.57
Price to Sales (P/S)2.49
Price to Cash Flow (P/CF)654.40
P/FCF Ratio5.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.28
Enterprise Value/Gross Profit2.27
Enterprise Value/Ebitda14.53
Price Target Upside272.09% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8



Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Trulieve Cannabis’s price range in the past 12 months?
Trulieve Cannabis lowest stock price was $3.83 and its highest was $16.11 in the past 12 months.
    What is Trulieve Cannabis’s market cap?
    Currently, no data Available
    When is Trulieve Cannabis’s upcoming earnings report date?
    Trulieve Cannabis’s upcoming earnings report date is Aug 10, 2023 which is in 66 days.
      How were Trulieve Cannabis’s earnings last quarter?
      Trulieve Cannabis released its earnings results on May 10, 2023. The company reported -$0.34 earnings per share for the quarter, missing the consensus estimate of -$0.156 by -$0.184.
        Is Trulieve Cannabis overvalued?
        According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Trulieve Cannabis pay dividends?
          Trulieve Cannabis does not currently pay dividends.
          What is Trulieve Cannabis’s EPS estimate?
          Trulieve Cannabis’s EPS estimate is -$0.17.
            How many shares outstanding does Trulieve Cannabis have?
            Trulieve Cannabis has 159,761,120 shares outstanding.
              What happened to Trulieve Cannabis’s price movement after its last earnings report?
              Trulieve Cannabis reported an EPS of -$0.34 in its last earnings report, missing expectations of -$0.156. Following the earnings report the stock price went down -2.963%.
                Which hedge fund is a major shareholder of Trulieve Cannabis?
                Currently, no hedge funds are holding shares in TCNNF


                Trulieve Cannabis Stock Smart Score

                The Trulieve Cannabis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Trulieve Cannabis

                Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Curaleaf Holdings
                Columbia Care
                Harmony Biosciences Holdings

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis